Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes

Approximately 20% of patients with pancreatic adenocarcinomas develop venous thromboembolisms, which reduces survival times. Preventing these thromboembolisms in patients might reduce mortality.